Timothy P Kelly's Net Worth
$118 Thousand
Who is Timothy P Kelly?
Timothy P Kelly does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Homology Medicines, Inc., and Caribou Biosciences, Inc..
SEC CIK
Timothy P Kelly's CIK is 0001754067
Past Insider Trading and Trends
2021 was Timothy P Kelly's most active year for acquiring shares with 12 total transactions. Timothy P Kelly's most active month to acquire stocks was the month of January. 2021 was Timothy P Kelly's most active year for disposing of shares, totalling 14 transactions. Timothy P Kelly's most active month to dispose stocks was the month of December. 2021 saw Timothy P Kelly paying a total of $133,350.83 for 105,232 shares, this is the most they've acquired in one year. In 2021 Timothy P Kelly cashed out on 28,286 shares for a total of $178,421.43, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Homology Medicines, Inc. (FIXX) Snapshot price: $0.715
Chief Operating Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 24
| |||
Form 4
|
∞
| 2.22K |
$3.78 | -$5,314.82 | 2.22K |
Scheduled
|
Jan 1 - Jan 5
| ||
Form 4
| -100.00% | -54.00 |
$7.70 | -$415.80 |
0
|
Scheduled
|
Sep 3
| ||
Form 4/A
| -100.00% | -6.23K |
$11.16 | -$69,562.83 |
0
|
Scheduled
|
Mar 1
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 7
| |||
Form 4
| +458.42% | 10.23K |
$8.66 | $88,615.03 |
0
|
Scheduled
|
Mar 1
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 5
| |||
Form 4
|
—
|
0
|
$9.82 | -$3,184.30 |
0
|
Scheduled
|
Feb 2
| ||
Form 4
|
—
|
0
|
$8.57 | -$30,407.80 |
0
|
Scheduled
|
Feb 1
| ||
Form 4
|
—
|
0
|
$9.82 | -$3,184.30 |
0
|
Scheduled
|
Jan 12
| ||
Form 4
|
—
|
0
|
$8.13 | -$26,930.60 |
0
|
Scheduled
|
Jan 4
| ||
Form 4
| -100.00% | -1.31K |
$13.01 | -$17,108.54 |
0
|
Scheduled
|
Mar 17
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 11
| |||
Form 4
| -100.00% | -1.17K |
$19.94 | -$23,251.44 |
0
|
Scheduled
|
Sep 5
| ||
Form 4
| -100.00% | -1.29K |
$20.00 | -$25,764.89 |
0
|
Scheduled
|
Jun 3
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Caribou Biosciences, Inc. (CRBU) Snapshot price: $6.55
Chief Technology Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||